|
Otonomy, Inc.
Ticker Symbol: OTIC* CUSIP: 68906L105 Exchange: OTOTC
* NOTE: This security is no longer trading as of 4/11/2023
Company's Online Profile
BUSINESS: Otonomy, Inc. is a biopharmaceutical company dedicated to the development of innovative therapeutics for diseases and disorders of the ear. The company pioneered the application of drug delivery technology to the ear in order to develop products that achieve sustained drug exposure from a single local administration.
|
IPO - 8/12/2014 - 6.25 Million Shares @ $16.00 /share.
Link to IPO Prospectus
Small Cap Stock -
Market Value $135.0 Million
|
Company's Online Information Links
|
| Company's Online SEC EDGAR Filings |
| Company's Email Address Links |
| Address and Phone Numbers |
| Address: 4796 Executive Drive, San Diego, CA 92121 |
| Main Phone Number |
619-323-2200 |
| Fax Number |
Not Available |
| Investor Relations
Robert H. Uhl, Westwicke Partners
|
858-356-5932
|
| CEO - David A. Weber, Ph.D. |
CFO - Paul E. Cayer |
Find a problem? Please use our Feedback Page or Email us.
Have you filled out our Guestbook? If not, please do.
|
|
